IMMUNOGENICITY AND SAFETY OF A THREE-DOSE SARS-COV-2 VACCINATION STRATEGY IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES ON IMMUNOSUPPRESSIVE THERAPY

Kristin Hammersbøen Bjørlykke  ¹     Ingrid Jyssum  ²     Anne Therese Tveter     Joseph Sexton     Ingrid E. Christensen     Trung T. Tran  ³     Siri Mjaaland  ⁴     David J. Warren     Tore K Kvien     Adity Chopra     Grete Birkeland Kro     Jørgen Jahnsen     Ludvig A. Munthe     Espen A Haavardsholm     Gunnveig Grødeland     John Torgils Vaage     Sella Aarrestad Provan     Guro Løvik Goll     Silje Watterdal Syversen     Kristin Kaasen Jørgensen    
¹ Akershus University Hospital, Lørenskog, Norway
² Diakonhjemmet Hospital, Oslo, Norway
³ Oslo University Hospital, Oslo, Norway
⁴ Norwegian Institute of Public Health, Oslo, Norway

Topic
IBD, Nurses, Primary Care

Session
COVID-19 still here: Lessons and questions

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)